Skip to main content
Top
Published in: Dermatology and Therapy 3/2024

Open Access 07-03-2024 | Lichen Sclerosus Et Atrophicus | Original Research

The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls

Authors: Agnieszka Dulska, Jakub Bodziony, Marta Janik, Agnieszka Drosdzol-Cop

Published in: Dermatology and Therapy | Issue 3/2024

Login to get access

Abstract

Introduction

Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition affecting the anogenital region, which can manifest in prepubertal or adolescent patients. The prevailing theories point to autoimmune and genetic factors. The primary symptoms of VLS typically include vulvar itching, discomfort, dysuria, and constipation. Physical examination often reveals a characteristic figure 8 pattern, involving the labia minora, clitoral hood, and perianal region. However, these symptoms and the age of onset are nonspecific and require differentiation from autoimmune dermatoses such as bullous diseases, pemphigus diseases, epidermolysis bullosa acquisita, and dermatitis herpetiformis. We performed this study to distinguish VLS from autoimmune dermatoses, and in doing so, uncover the underlying causes of chronic vulvar changes. This knowledge will enable healthcare providers to offer appropriate medical care to affected patients.

Methods

The study was conducted between July 2020 and February 2021, with a sample of 55 girls aged 2–18 years who did not have any systemic diseases. The study group was composed of 20 girls previously diagnosed with vulvar lichen sclerosus, while the control group included 35 girls without VLS. Questionnaires regarding the medical history of the children were completed by their legal guardians. Blood samples were collected and analyzed biochemically to assess human immunoglobulin A (IgA), IgG, and IgM antibodies against various substrates, including the desmosome of stratum spinosum, basement membrane zone, desmoglein 1 (DSG1), desmoglein 3 (DSG3), BP180-NC16A-4X, BP230gC, pemphigoid antigen, collagen type VII NC1, transitional epithelium, gliadin (GAF-3X), endomysium (EMA), and cellular nucleus (ANA).

Results

The analysis of the study group revealed that the most commonly observed signs and symptoms included: itching, soreness, burning sensations, and excoriation, as well as erythema or/and pallor of the skin and perineal mucosa. Among the assessed antibodies, only anti-GAF3x antibodies and ANA antibodies were detected. However, the results did not reach statistical significance (p > 0.5).
Literature
1.
go back to reference Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J. 2012;59:A4424.PubMed Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J. 2012;59:A4424.PubMed
4.
go back to reference Barnadas MA, Rubiales MV, Gonzalez MJ, Puig L, Pilar G, Baselga E, Pujol R, Alomar A, Gelpi C. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int J Dermatol. 2008;47:1245–9.CrossRefPubMed Barnadas MA, Rubiales MV, Gonzalez MJ, Puig L, Pilar G, Baselga E, Pujol R, Alomar A, Gelpi C. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int J Dermatol. 2008;47:1245–9.CrossRefPubMed
5.
go back to reference Damoiseaux J, van Rijsingen M, Warnemünde* N, Dähnrich* C, Fechner* K, Cohen Tervaert JW. (*EUROIMMUN AG). Autoantibody detection in bullous pemphigoid: Clinical evaluation of the EUROPLUSTM Dermatology Mosaic. J Immunol Methods 382 (2012) 76–80. Damoiseaux J, van Rijsingen M, Warnemünde* N, Dähnrich* C, Fechner* K, Cohen Tervaert JW. (*EUROIMMUN AG). Autoantibody detection in bullous pemphigoid: Clinical evaluation of the EUROPLUSTM Dermatology Mosaic. J Immunol Methods 382 (2012) 76–80.
17.
go back to reference Borghi A, Flacco ME, Schettini N, Toni G, Corazza M. “Searching for a ‘window of opportunity’ in the treatment of vulvar lichen sclerosus: evidence for therapeutic benefits of an early corticosteroid treatment.” Dermatology. 2024. doi: https://doi.org/10.1159/000535849 Borghi A, Flacco ME, Schettini N, Toni G, Corazza M. “Searching for a ‘window of opportunity’ in the treatment of vulvar lichen sclerosus: evidence for therapeutic benefits of an early corticosteroid treatment.” Dermatology. 2024. doi: https://​doi.​org/​10.​1159/​000535849
Metadata
Title
The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls
Authors
Agnieszka Dulska
Jakub Bodziony
Marta Janik
Agnieszka Drosdzol-Cop
Publication date
07-03-2024
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 3/2024
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-024-01124-0

Other articles of this Issue 3/2024

Dermatology and Therapy 3/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.